European Primary Care Cardiovascular Society
EPCCS Annual CV Summit

Recent updates to the international Hypertension Guidelines - where do they vary and what should we agree in primary care?

5' education - Mar. 21, 2019 - Lisbon, Portugal - Richard McManus & Richard Hobbs
EPCCS Annual CV Summit

Multimorbidity, CV disease and polypharmacy

10' education - Mar. 21, 2019 - Lisbon, Portugal - Dr. David Silvério Rodrigues

Lifestyle improvement forms the basis of comprehensive ACC/AHA guideline for primary prevention

3' education - Mar. 20, 2019 - New Orleans, LA, USA - Dr. Amit Khera

Implementation of advice facilitated by new overarching recommendations in ACC/AHA primary prevention guideline

3' education - Mar. 20, 2019 - New Orleans, LA, USA - Donna Arnett, MD

84% True AF in those with irregular pulse detected with smartwatch in proof-of-concept study

3' education - Mar. 20, 2019 - New Orleans, LA, USA - Michael Valentine, MD

First ischemic events and recurrent events reduced with highly purified omega-3 fatty acid

3' education - Mar. 20, 2019 - New Orleans, LA, USA - Deepak L. Bhatt, MD

ESC/ESH Guidelines on management of hypertension: what's new?

3' education - Feb. 11, 2019 - Prof. Bryan Williams - London, UK

EPCCS

3' education - Feb. 8, 2019

EPCCS society: what is available for members?

3' education - Feb. 7, 2019 - Prof. Richard Hobbs, MD

May Measurement Month: Get involved to increase awareness on elevated blood pressure

3' education - Feb. 6, 2019 - Prof. Neil Poulter - London, UK

Primary prevention of CV events with aspirin: yes or no?

3' education - Jan. 31, 2019 - Prof. dr. Freek Verheugt - Amsterdam, The Netherlands

HFpEF: What is it & size of the problem

10' education - Aug. 27, 2018 - Prof. Adriaan Voors - Groningen, The Netherlands

HFpEF: Current and future clinical approaches to manage HFpEF

10' education - Aug. 27, 2018 - Burkert Pieske, MD - Berlin, Germany

HFpEF: What are the most likely pathophysiological mechanisms involved in the disease

10' education - Aug. 27, 2018 - Carolyn Lam, MD - Singapore

HFpEF: How to diagnose

10' education - Aug. 27, 2018 - Barry Borlaug - Rochester, MN, USA

Primary Cardiovascular Care in Spain (Spanish)

5' education - Jan. 10, 2019 - EPCCS Council Berlin - Francisco Javier Sanz Garcia

Primary Cardiovascular Care in Spain (English)

5' education - Jan. 10, 2019 - EPCCS Council Berlin - Francisco Javier Sanz Garcia

The cardiovascular challenge for primary care in diabetes

10' education - July 10, 2018 - Prof. Richard Hobbs - Oxford, UK

Primary Cardiovascular Care in Romania (Romanian)

5' education - Dec. 17, 2018 - EPCCS Council Berlin - Mihaela Daniela Balta

Primary Cardiovascular Care in Montenegro (Montenegrin)

5' education - Dec. 17, 2018 - EPCCS Council Berlin - Assist. Prof. dr. Milena Cojić

Education, exchange, guidance and interaction during EPCCS Summit 2019

EPCCS Annual CV Summit

EPCCS 2019 Read impressions of the updates on stroke prevention in AF, hypertension, HF and CV risk in diabetes, with emphasis on challenges faced in patients with multimorbidities.

Recent updates to the international Hypertension Guidelines - where do they vary and what should we agree in primary care?

5' education - Mar. 21, 2019 - Lisbon, Portugal - Richard McManus & Richard Hobbs
Profs. McManus and Hobbs consider the latest recommendations and insights on how to diagnose elevated blood pressure and when to initiate treatment.

Profs. McManus and Hobbs consider the latest recommendations and insights on how to diagnose elevated blood pressure and when to initiate treatment.

Multimorbidity, CV disease and polypharmacy

10' education - Mar. 21, 2019 - Lisbon, Portugal - Dr. David Silvério Rodrigues
Dr. Rodrigues zooms in on an individual patient case to illustrate the complexity of management of patients with multimorbidity and polypharmacy.

EPCCS 2019 Dr. Rodrigues zooms in on an individual patient case to illustrate the complexity of management of patients with multimorbidity and polypharmacy.

Increased risk of incident CVD and mortality with higher consumption of dietary cholesterol or eggs

Literature - Apr. 4, 2019 - Zhong VW et al. - JAMA 2019
Among US adults, higher consumption of dietary cholesterol or eggs was significantly associated with higher risk of incident CVD and all-cause mortality in a dose-response manner.

Among US adults, higher consumption of dietary cholesterol or eggs was significantly associated with higher risk of incident CVD and all-cause mortality in a dose-response manner.

Complexities of managing heart failure

EPCCS Annual CV Summit

EPCCS Annual CV Summit

EPCCS 2019 Read an impression of the presentation of prof. Van der Meer, on the latest recommendations on management of HF, including important aspects to consider in patients with comorbidities.

Diabetes and cardiovascular risk

EPCCS Annual CV Summit

EPCCS 2019 Prof. Hobbs set the scene for the presentation of prof. Khunti, by showing how diabetes is linked to CVD risk, after which prof. Khunti outlined how this risk can best be reduced with therapy.

Update on stroke prevention in atrial fibrillation

EPCCS Annual CV Summit

EPCCS 2019 In a comprehensive talk, professor Hobbs considered a range of aspects relevant to the management of patients with atrial fibrillation (AF), the most common cardiac arrhythmia. Read an impression

How to deal with the challenges of multimorbidity in general practice?

EPCCS Annual CV Summit

EPCCS 2019 In case-based discussions, various complexities of management of patients with multimorbity and polypharmacy were discussed, and strategies to deal with this were exchanged.

EPCCS Council meeting: fruitful exchange on how to expand the EPCCS network

News - Mar. 21, 2019

Prior to the Annual CV Summit, country representatives of the EPCCS Council gathered in Lisbon to discuss the next necessary steps to expand our European network of GP’s.

Less brain damage with intensive BP-lowering in older hypertensives, but no effect on function

Mar. 20, 2019

ACC 2019 The randomized INFINITY trial showed a reduction in accrual of subcortical white matter disease in older people treated to 130 vs. 145 mmHg, but that did not improve mobility and cognitive function.

Cholesterol synthesis inhibitor safely lowers LDL-c in high risk patients on lipid-lowering therapy

Mar. 20, 2019

ACC 2019 Results of the CLEAR Wisdom trial showed that bempedoic acid lowered LDL-c in high CV risk patients with elevated LDL-c levels who are on maximally tolerated statin and/or other lipid-modifying therapies.

Lifestyle improvement forms the basis of comprehensive ACC/AHA guideline for primary prevention

3' education - Mar. 20, 2019 - New Orleans, LA, USA - Dr. Amit Khera
**ACC 2019** Dr. Khera explains how the guideline writing committee aimed to compose a comprehensive document to cover all facets of prevention. He discusses some recommendations, including a clear message on aspirin.

ACC 2019 Dr. Khera explains how the guideline writing committee aimed to compose a comprehensive document to cover all facets of prevention. He discusses some recommendations, including a clear message on aspirin.